XTYW011

N/A

Report date: 2023/03/16 16:13:05
NME

Base Information

Drug NameXTYW011
Drug Alias NameXTYW-011XTYW011
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK3 inhibitors
TargetsTyrosine-protein kinase JAK3
Therapy Area/IndicationsAlopecia AreataArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChina Pharmaceutical UniversityXi'an Xintong Pharmaceutical Research Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesXi'an Xintong Pharmaceutical Research Co LtdChina Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsAlopecia AreataArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A